RNTX
Rein Therapeutics
RNTX
RNTX
46 hedge funds and large institutions have $14.8M invested in Rein Therapeutics in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.44% less ownership
Funds ownership: 41.08% → 40.65% (-0.44%)
4% less funds holding
Funds holding: 48 → 46 (-2)
Holders
46
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$362K | |
| 2 | +$223K | |
| 3 | +$179K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$126K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$74.6K |
Top Sellers
| 1 | -$139K | |
| 2 | -$71.9K | |
| 3 | -$68.4K | |
| 4 |
Two Sigma Investments
New York
|
-$48.4K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$38.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
51
Virtu Financial
New York
| – |
|
|||
52
Cetera Investment Advisers
Schaumburg,
Illinois
| – |
|
|||
53
Osaic Holdings
Scottsdale,
Arizona
| – |
|
|||
54
Bank of America
Charlotte,
North Carolina
| – |
|